Get started
Author

Emma Geatches

Provisional extracellular matrix signaling network regulates tumor lymphoneogenesis and response to immunotherapy
2026 · Daniel J. Lagal, Duncan Hong, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Reviewer #2 (Public review): CD56dimCD16dim NK cells are the dominant effector cells against HIV-infected primary T-cells
2026 · William Howell, Courtney Branch, et al.
CD56dimCD16dim NK cells are the dominant effector cells against HIV-infected primary T-cells
2026 · William Howell, Courtney Branch, et al. · eLife
PDF
Author response: CD56dimCD16dim NK cells are the dominant effector cells against HIV-infected primary T-cells
2026 · William Howell, Courtney Branch, et al.
CD56dimCD16dim NK cells are the dominant effector cells against HIV-infected primary T-cells
2026 · William Howell, Courtney Branch, et al. · eLife
PDF
Reviewer #1 (Public review): CD56dimCD16dim NK cells are the dominant effector cells against HIV-infected primary T-cells
2026 · William Howell, Courtney Branch, et al.
CD56 dim CD16 dim NK cells are the dominant effector cells against HIV-infected primary T-cells
2026 · William Howell, Courtney Branch, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Abstract 6746: Biomarker-driven restoration of tumor provisional matrix signaling network reverses resistance to checkpoint inhibition immunotherapy
2026 · Daniel J. Lagal, Duncan Hong, et al. · Cancer Research
Works count: 8
Citation count:
H-index:
I10-index:
Year
Topic
Type